CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-3,691 Cr | ₹-2,988 Cr | ₹-2,389 Cr | ₹-1,872 Cr | ₹-2,387 Cr |
What is the latest Cash Flow from Investing Activities ratio of CIPLA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2025 | ₹-3,691 Cr |
Mar2024 | ₹-2,988 Cr |
Mar2023 | ₹-2,389 Cr |
Mar2022 | ₹-1,872 Cr |
Mar2021 | ₹-2,387 Cr |
How is Cash Flow from Investing Activities of CIPLA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-3,691 Cr | Negative | |
Mar2024 | ₹-2,988 Cr | Negative | |
Mar2023 | ₹-2,389 Cr | Negative | |
Mar2022 | ₹-1,872 Cr | Negative | |
Mar2021 | ₹-2,387 Cr | - |
Compare Cash Flow from Investing Activities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹127,131.6 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 0.1% | 6.1% | 6.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.1% |
3.5% |
-4.4% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses